Literature DB >> 18179568

Serum uric acid and lipid levels while taking topiramate for migraine.

Abdulkadir Koçer1, Süber Dikici, Selcuk Atakay, Sefika Okuyucu.   

Abstract

OBJECTIVE: Topiramate (TPM) therapies for epilepsy or migraine are long-time therapies with unknown mechanisms and special side effects. TPM influences cholesterol (TC) and lipoprotein serum levels. In addition, TPM may cause uric acid (UA) stone formation.
MATERIAL AND METHODS: Serum UA, TC, and triglyceride (TG) levels were measured in 53 migraine patients receiving TPM and in 44 age- and sex-matched controls. Compared with controls, patients on TPM showed significantly higher UA and nonsignificantly higher TC and TG values. We recorded pre- and posttreatment levels of UA, TC, and TG levels in 23 patients.
RESULTS: We found increased serum levels of UA with TPM use (P < .01). There was a significant and positive correlation between serum UA levels and male gender (P < .01).The changes in serum UA levels before and after TPM treatment differed significantly (P < .01).
CONCLUSION: Our results suggest a need for monitoring serum UA levels in patients receiving TPM. We should perhaps prescribe a low-UA diet and advice to drink much more water in these patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18179568     DOI: 10.1111/j.1526-4610.2007.01008.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  5 in total

1.  Effects of topiramate use on body composition and resting metabolic rate in migraine patients.

Authors:  Mehmet Yaman; Kagan Ucok; Hayri Demirbas; Abdurrahman Genc; Serdar Oruc; Hatice Karabacak; Gokhan Koyuncu
Journal:  Neurol Sci       Date:  2012-03-06       Impact factor: 3.307

Review 2.  Metabolic disturbances and renal stone promotion on treatment with topiramate: a systematic review.

Authors:  Valentina G Dell'Orto; Eva A Belotti; Barbara Goeggel-Simonetti; Giacomo D Simonetti; Gian Paolo Ramelli; Mario G Bianchetti; Sebastiano A G Lava
Journal:  Br J Clin Pharmacol       Date:  2014-06       Impact factor: 4.335

3.  Topiramate-induced modulation of hepatic molecular mechanisms: an aspect for its anti-insulin resistant effect.

Authors:  Hanan S El-Abhar; Mona F Schaalan
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

4.  An Exponential Curve Relationship Between Serum Urate and Migraine: A Cross-Section Study From NHANES.

Authors:  Peiwei Hong; Yao Liu; Yang Wan; Hai Xiong; Yanming Xu
Journal:  Front Neurol       Date:  2022-04-15       Impact factor: 4.086

5.  Metabolic syndrome and migraine.

Authors:  Amit Sachdev; Michael J Marmura
Journal:  Front Neurol       Date:  2012-11-19       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.